EYETRONIC

Company

EYETRONIC develops one asset, in human trials (Eyetronic rtACS in glaucoma). Mostly device.

1
Asset
Furthest stage
Human trials
0
Trials
1
Signal

Pipeline

1
  • Eyetronic rtACS

    Applies transorbital alternating current stimulation to enhance visual function in glaucoma.

    Human trials, Device, glaucoma, glaucoma open-angle

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals1
  • Similar companies4

Intelligence